Evaluating the various phases of cisplatin‑induced emesis in rats

Shi,Jun

doi:10.3892/ol.2014.2506

Evaluating the various phases of cisplatin‑induced emesis in rats

Authors:
- Jun Shi
View Affiliations

Affiliations: Department of Traditional Chinese Medicine, Shanghai Changzheng Hospital, The Second Military Medical University, Shanghai 200003, P.R. China
Published online on: September 5, 2014 https://doi.org/10.3892/ol.2014.2506
Pages: 2017-2022

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Use of cisplatin as a chemotherapeutic agent causes acute and delayed emesis. Kaolin, saccharin solution and normal feed consumption have been evaluated as an index of cisplatin‑induced emesis in rats; however, the most preferable of these methods for evaluating the various phases of emesis remains unclear. In the current study, kaolin, saccharin solution and normal feed consumption following cisplatin administration (6 mg/kg intraperitoneally) were simultaneously investigated in rats. Kaolin consumption increased significantly following cisplatin administration and was attenuated by granisetron administration 0‑24 h following the injection. Saccharin solution consumption, however, decreased significantly 0‑48 h following cisplatin administration, however, was attenuated by administration of granisetron within 0‑24 h only. A reduced intake of normal feed was observed in the control group and was reversed by granisetron within the 0‑72 h period. The present study indicates that kaolin consumption may be evaluated as an index of cisplatin‑induced acute emesis and saccharin solution consumption may be evaluated as an index of delayed emesis, while normal feed consumption as an indicator of anorexia nervosa may be suitable to evaluate all phases of emesis and serve as an indicator of quality of life.

View Figures

View References

1	Rudd JA, Jordan CC and Naylor RJ: The action of the NK1 tachykinin receptor antagonist, CP 99,994, in antagonizing the acute and delayed emesis induced by cisplatin in the ferret. Br J Pharmacol. 119:931–936. 1996.
2	Gardner CJ, Armour DR, Beattie DT, et al: GR205171: a novel antagonist with high affinity for the tachykinin NK1 receptor, and potent broad-spectrum anti-emetic activity. Regul Pept. 65:45–53. 1996.
3	Rudd JA and Naylor RJ: An interaction of ondansetron and dexamethasone antagonizing cisplatin-induced acute and delayed emesis in the ferret. Br J Pharmacol. 118:209–214. 1996.
4	Takeda N, Hasegawa S, Morita M and Matsunaga T: Pica in rats is analogous to emesis: an animal model in emesis research. Pharmacol Biochem Behav. 45:817–821. 1993.
5	De Jonghe BC and Horn CC: Chemotherapy-induced pica and anorexia are reduced by common hepatic branch vagotomy in the rat. Am J Physiol Regul Integr Comp Physiol. 294:R756–R765. 2008.
6	Garcia J, Hankins WG and Rusiniak KW: Behavioral regulation of the milieu interne in man and rat. Science. 185:824–831. 1974.
7	Liu Y, Hamaue N, Endo T, Hirafuji M and Minami M: 5-hydroxytryptamine (5-HT) concentrations in the hippocampus, the hypothalamus and the medulla oblongata related to cisplatin-induced pica of rats. Res Commun Mol Pathol Pharmacol. 113–114:97–113. 2003.
8	Horn CC, De Jonghe BC, Matyas K and Norgren R: Chemotherapy-induced kaolin intake is increased by lesion of the lateral parabrachial nucleus of the rat. Am J Physiol Regul Integr Comp Physiol. 297:R1375–R1382. 2009.
9	Saito R and Takano Y: Easy method for emesis using rats. Nihon Yakurigaku Zasshi. 127:461–466. 2006.(In Japanese).
10	Mehendale SR, Aung HH, Yin JJ, et al: Effects of antioxidant herbs on chemotherapy-induced nausea and vomiting in a rat-pica model. Am J Chin Med. 32:897–905. 2004.
11	Yamamoto K, Matsunaga S, Matsui M, Takeda N and Yamatodani A: Pica in mice as a new model for the study of emesis. Methods Find Exp Clin Pharmacol. 24:135–138. 2002.
12	Takeda N, Hasegawa S, Morita M, et al: Neuropharmacological mechanisms of emesis. II. Effects of antiemetic drugs on cisplatin-induced pica in rats. Methods Find Exp Clin Pharmacol. 17:647–652. 1995.
13	Liu YL, Malik N, Sanger GJ, Friedman MI and Andrews PL: Pica - a model of nausea? Species differences in response to cisplatin. Physiol Behav. 85:271–277. 2005.
14	Cai YL, Ma WL, Li M, et al: Behavioral changes of rats under rotation stimulation. Space Med Med Eng (Beijing). 18:98–101. 2005.(In Chinese).
15	Rudd JA, Ngan MP and Wai MK: 5-HT3 receptors are not involved in conditioned taste aversions induced by 5-hydroxytryptamine, ipecacuanha or cisplatin. Eur J Pharmacol. 352:143–149. 1998.
16	Mele PC, McDonough JR, McLean DB and O’Halloran KP: Cisplatin-induced conditioned taste aversion: attenuation by dexamethasone but not zacopride or GR38032F. Eur J Pharmacol. 218:229–236. 1992.
17	Yakabi K, Sadakane C, Noguchi M, et al: Reduced ghrelin secretion in the hypothalamus of rats due to cisplatin-induced anorexia. Endocrinology. 151:3773–3782. 2010.
18	Ando K, Takagi K and Tsubone H: Enhanced gastric retention of solid resin beads as a marker for emetic potential of agents in rats. J Toxicol Sci. 37:549–553. 2012.
19	Cabezos PA, Vera G, Castillo M, et al: Radiological study of gastrointestinal motor activity after acute cisplatin in the rat. Temporal relationship with pica. Auton Neurosci. 141:54–65. 2008.
20	Mitchell D, Wells C, Hoch N, et al: Poison induced pica in rats. Physiol Behav. 17:691–697. 1976.
21	Aung HH, Mehendale SR, Xie JT, Moss J and Yuan CS: Methylnaltrexone prevents morphine-induced kaolin intake in the rat. Life Sci. 74:2685–2691. 2004.
22	Kris MG, Hesketh PJ, Somerfield MR, et al; American Society of Clinical Oncology. American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006. J Clin Oncol. 24:2932–2947. 2006.
23	Rojas C, Li Y, Zhang J, et al: The antiemetic 5-HT3 receptor antagonist Palonosetron inhibits substance P-mediated responses in vitro and in vivo. J Pharmacol Exp Ther. 335:362–368. 2010.
24	Darmani NA, Crim JL, Janoyan JJ, Abad J and Ramirez J: A re-evaluation of the neurotransmitter basis of chemotherapy-induced immediate and delayed vomiting: evidence from the least shrew. Brain Res. 1248:40–58. 2009.
25	Yamamoto K, Ngan MP, Takeda N, Yamatodani A and Rudd JA: Differential activity of drugs to induce emesis and pica behavior in Suncus murinus (house musk shrew) and rats. Physiol Behav. 83:151–156. 2004.
26	Vera G, Chiarlone A, Cabezos PA, et al: WIN 55,212-2 prevents mechanical allodynia but not alterations in feeding behaviour induced by chronic cisplatin in the rat. Life Sci. 81:468–479. 2007.
27	Batra VR and Schrott LM: Acute oxycodone induces the pro-emetic pica response in rats. J Pharmacol Exp Ther. 339:738–745. 2011.
28	Jeong SW, Cho JW, Hwang JS, et al: The antiemetic effect of a novel tropisetron patch in anticancer agents-induced kaolin pica model using rats. Environ Toxicol Pharmacol. 20:167–174. 2005.
29	Fujisaki Y, Yamauchi A, Shuto H, et al: Pharmacological characterization of cyclosporine A-induced kaolin intake in rats. Pharmacol Biochem Behav. 70:267–271. 2001.
30	Malik NM, Liu YL, Cole N, Sanger GJ and Andrews PL: Differential effects of dexamethasone, ondansetron and a tachykinin NK1 receptor antagonist (GR205171) on cisplatin-induced changes in behaviour, food intake, pica and gastric function in rats. Eur J Pharmacol. 555:164–173. 2007.
31	Vera G, Chiarlone A, Martín MI and Abalo R: Altered feeding behaviour induced by long-term cisplatin in rats. Auton Neurosci. 126–127:81–92. 2006.
32	Yamamoto K, Nakai M, Nohara K and Yamatodani A: The anti-cancer drug-induced pica in rats is related to their clinical emetogenic potential. Eur J Pharmacol. 554:34–39. 2007.
33	Saeki M, Sakai M, Saito R, et al: Effects of HSP-117, a novel tachykinin NK1-receptor antagonist, on cisplatin-induced pica as a new evaluation of delayed emesis in rats. Jpn J Pharmacol. 86:359–362. 2001.
34	Rudd JA, Yamamoto K, Yamatodani A and Takeda N: Differential action of ondansetron and dexamethasone to modify cisplatin-induced acute and delayed kaolin consumption (‘pica’) in rats. Eur J Pharmacol. 454:47–52. 2002.
35	Cabezos PA, Vera G, Martín-Fontelles MI, Fernández-Pujol R and Abalo R: Cisplatin-induced gastrointestinal dysmotility is aggravated after chronic administration in the rat. Comparison with pica. Neurogastroenterol Motil. 22:797–805. 2010.
36	Horn CC, Ciucci M and Chaudhury A: Brain Fos expression during 48 h after cisplatin treatment: neural pathways for acute and delayed visceral sickness. Auton Neurosci. 132:44–51. 2007.
37	Wang CZ, Basila D, Aung HH, et al: Effects of Ganoderma lucidum extract on chemotherapy-induced nausea and vomiting in a rat model. Am J Chin Med. 33:807–815. 2005.
38	Mehendale S, Aung H, Wang A, et al: American ginseng berry extract and ginsenoside Re attenuate cisplatin-induced kaolin intake in rats. Cancer Chemother Pharmacol. 56:63–69. 2005.
39	Du J, Li P, Sun X and Zhang M: Ameliorative effect of Armillariella tabescens on cisplatin-induced gastrointestinal tract reaction in the rat. Zhonghua Zhong Liu Za Zhi. 33:579–582. 2011.(In Chinese).
40	Qian Q, Chen W, Guo C, et al: Xiao-Ban-Xia-Tang inhibits cisplatin-induced pica by down regulating obestatin in rats. J Ethnopharmacol. 135:186–193. 2011.
41	Wang CZ, Fishbein A, Aung HH, et al: Polyphenol contents in grape-seed extracts correlate with antipica effects in cisplatin-treated rats. J Altern Complement Med. 11:1059–1065. 2005.
42	Tatsushima Y, Egashira N, Matsushita N, et al: Pemirolast reduces cisplatin-induced kaolin intake in rats. Eur J Pharmacol. 661:57–62. 2011.
43	Aung HH, Dey L, Mehendale S, et al: Scutellaria baicalensis extract decreases cisplatin-induced pica in rats. Cancer Chemother Pharmacol. 52:453–458. 2003.
44	De Jonghe BC, Lawler MP, Horn CC and Tordoff MG: Pica as an adaptive response: Kaolin consumption helps rats recover from chemotherapy-induced illness. Physiol Behav. 97:87–90. 2009.
45	Cairnie AB and Leach KE: Dexamethasone: a potent blocker for radiation-induced taste aversion in rats. Pharmacol Biochem Behav. 17:305–311. 1982.
46	Geerse GJ, van Gurp LC, van Wijk DC, Wiegant VM and Stam R: Duodenal pain and spinal morphine induce conditioned taste aversion in rats. Physiol Behav. 91:310–317. 2007.
47	Wu XW, Xin B, Zou JF, et al: Effect of rotation stimulation on the anesthetic sensitivity of sevoflurane in rats. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 28:114–117. 2012.(In Chinese).
48	Garcia J, Rusiniak KW and Brett LP: Conditioning food-illness aversions in wild animals: Caveant canonici. Operant-Pavlovian Interactions. Davis H and Hurwitz H: Lawrence Erlbaum Associates; Hillsdale, NJ: pp. 45–86. 1977
49	Smith JE, Friedman MI and Andrews PL: Conditioned food aversion in Suncus murinus (house musk shrew) - a new model for the study of nause in a species with an emetic reflex. Physiol Behav. 73:593–598. 2001.
50	Cross-Mellor SK, Ossenkopp KP, Piomelli D and Parker LA: Effects of the FAAH inhibitor, URB597, and anandamide on lithium-induced taste reactivity responses: a measure of nausea in the rat. Psychopharmacology (Berl). 190:135–143. 2007.
51	Riley AL and Freeman KB: Conditioned taste aversion: a database. Pharmacol Biochem Behav. 77:655–656. 2004.
52	McAllister KH and Pratt JA: GR205171 blocks apomorphine and amphetamine-induced conditioned taste aversions. Eur J Pharmacol. 353:141–148. 1998.
53	Anderson RI, Agoglia AE, Morales M, Varlinskaya EI and Spear LP: Stress, κ manipulations, and aversive effects of ethanol in adolescent and adult male rats. Neuroscience. 249:214–222. 2013.
54	Shinpo K, Hirai Y, Maezawa H, Totsuka Y and Funahashi M: The role of area postrema neurons expressing H-channels in the induction mechanism of nausea and vomiting. Physiol Behav. 107:98–103. 2012.
55	Bienkowski P, Kuca P, Piasecki J and Kostowski W: 5-HT3 receptor antagonist, tropisetron, does not influence ethanol-induced conditioned taste aversion and conditioned place aversion. Alcohol. 14:63–69. 1997.
56	Raghavendran HR, Rekha S, Shin JW, et al: Effects of Korean ginseng root extract on cisplatin-induced emesis in a rat-pica model. Food Chem Toxicol. 49:215–221. 2011.
57	Liu YL, Malik NM, Sanger GJ and Andrews PL: Ghrelin alleviates cancer chemotherapy-associated dyspepsia in rodents. Cancer Chemother Pharmacol. 58:326–333. 2006.